MFN2 and Alzheimer disease: Pretreatment with SS-31 also reversed alterations in the expression of the mitochondrial proteins dynamin-related protein (DRP) 1, FIS1, mitofusin (MFN) 1, MFN2, and OPA1 in Alzheimer disease [35].